Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics Previous close 5,070.10
Open 5,070.10
Day range —
52-week range 1,830.00 5,075.04
Off day high 0.00%
Off 52-week high −0.10%
Volume 30.00
Avg. volume (3M) 90.00
Market cap 765.59B
EPS (TTM) 96.45
Forward P/E —
P/E ratio (TTM) 52.57
Dividend yield —
Beta (5Y) —
Shares outstanding 151.00M
Short interest —
Earnings date Oct 29, 2026
Analyst target —
Profit margin —
No recent coverage in the 4Search index.
From articles in the 4Search news index.
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.
From Wikipedia , CC BY-SA 4.0
Earnings
Next report: Thu, Oct 29, 2026
Not eligible for Gainers, Losers, Most active (U.S. stocks worth $2 billion or more only).
Not eligible for Small-cap gainers, Aggressive small caps (U.S. stocks worth under $2 billion only).
Not eligible for Growth tech (U.S. technology stocks only).
Not eligible for Undervalued large caps (U.S. stocks worth $10 billion or more only).
A day counts when it ranked in the top 25 of a list. Tracked since Oct 10, 2026.
Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use .